Kevin Tang
@Tang Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$1.4BTotal holdings154
Assets growth rate42.57%Assets growth rate (2-Q avg)22.41%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Tang Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 154 positions.
Assets under management
The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.4B in assets, with a quarterly growth rate of 42.57% and a 2-quarter average growth rate of 22.41%. The portfolio is managed by Kevin Tang, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EOLSEvolus Inc
| 5.61% | $78.528M 4.847M shares@ $16.21 avg price | |
TARSTarsus Pharmaceuticals Inc
| 5.3% | $74.16M 2.255M shares@ $32.89 avg price | |
AUPHAurinia Pharmaceuticals Inc
| 3.79% | $52.992M 7.23M shares@ $7.33 avg price | Increased 160.11% |
VRDNViridian Therapeutics Inc
| 3.65% | $51.027M 2.243M shares@ $22.76 avg price | Increased 61.03% |
MIRMMirum Pharmaceuticals Inc
| 3.59% | $50.197M 1.287M shares@ $39.0 avg price | |
KALVKalvista Pharmaceuticals Inc
| 3.58% | $50.044M 4.322M shares@ $11.58 avg price | Increased 2.44% |
ANABAnaptysbio Inc
| 3.19% | $44.584M 1.331M shares@ $33.51 avg price | |
IMCRImmunocore Hldgs Plc
| 2.46% | $34.417M 1.106M shares@ $31.13 avg price | Increased 172.59% |
PCVXVaxcyte Inc
| 2.45% | $34.281M 300,000 shares@ $114.27 avg price | |
BNTXBiontech Se
| 2.3% | $32.068M 270,000 shares@ $118.77 avg price | New Position |